Serveur d'exploration Tocilizumab

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Le cluster Luigi Boiardi - Nicol Pipitone

Terms

8Luigi Boiardi
12Nicol Pipitone
33Carlo Salvarani
6Francesco Muratore

Associations

Freq.WeightAssociation
70.714Luigi Boiardi - Nicol Pipitone
120.603Carlo Salvarani - Nicol Pipitone
80.492Carlo Salvarani - Luigi Boiardi
60.426Carlo Salvarani - Francesco Muratore

Documents par ordre de pertinence
001099 (2018) Francesco Muratore [Italie] ; Giulia Pazzola [Italie] ; Alessandra Soriano [Italie] ; Nicol Pipitone [Italie] ; Stefania Croci [Italie] ; Martina Bonacini [Italie] ; Luigi Boiardi [Italie] ; Carlo Salvarani [Italie]Unmet Needs in the Pathogenesis and Treatment of Vasculitides.
001669 (2017) Francesco Muratore [Italie] ; Nicol Pipitone [Italie] ; Carlo Salvarani [Italie]Standard and biological treatment in large vessel vasculitis: guidelines and current approaches.
001A70 (2016) Francesco Muratore [Italie] ; Giulia Pazzola [Italie] ; Nicol Pipitone [Italie] ; Carlo Salvarani [Italie]Recent advances in the diagnosis and treatment of polymyalgia rheumatica.
002679 (2013) Pierluigi Macchioni [Italie] ; Luigi Boiardi ; Mariagrazia Catanoso ; Lia Pulsatelli ; Nicol Pipitone ; Riccardo Meliconi ; Carlo SalvaraniTocilizumab for polymyalgia rheumatica: report of two cases and review of the literature.
002751 (2013) Augusto Vaglio [Italie] ; Maria G. Catanoso ; Lucia Spaggiari ; Luca Magnani ; Nicol Pipitone ; Pierluigi Macchioni ; Lia Pulsatelli ; Maria Nicastro ; Gabriella Becchi ; Domenico Corradi ; Annibale Versari ; Luigi Boiardi ; Carlo SalvaraniInterleukin-6 as an inflammatory mediator and target of therapy in chronic periaortitis.
003416 (2012) Carlo Salvarani [Italie] ; Luca Magnani ; Mariagrazia Catanoso ; Nicol Pipitone ; Annibale Versari ; Lucia Dardani ; Lia Pulsatelli ; Riccardo Meliconi ; Luigi BoiardiTocilizumab: a novel therapy for patients with large-vessel vasculitis.
003912 (2011) Mariagrazia Catanoso [Italie] ; Nicol Pipitone ; Luca Magnani ; Luigi Boiardi ; Carlo SalvaraniNew indications for biological therapies.
004122 (2008) Carlo Salvarani [Italie] ; Nicol Pipitone [Italie] ; Luigi Boiardi [Italie] ; Gene G. Hunder [États-Unis]Do we need treatment with tumour necrosis factor blockers for giant cell arteritis?
004341 (????) Carlo Salvarani [Italie] ; Luca Magnani ; Maria Grazia Catanoso ; Nicol Pipitone ; Annibale Versari ; Lucia Dardani ; Lia Pulsatelli ; Riccardo Meliconi ; Luigi BoiardiRescue treatment with tocilizumab for Takayasu arteritis resistant to TNF-α blockers.
000448 (2020) Martina Bonacini [Italie] ; Alessandra Soriano [Italie] ; Luca Cimino [Italie] ; Luca De Simone [Italie] ; Elena Bolletta [Italie] ; Fabrizio Gozzi [Italie] ; Francesco Muratore [Italie] ; Maria Nicastro [Italie] ; Lucia Belloni [Italie] ; Alessandro Zerbini [Italie] ; Luigi Fontana [Italie] ; Carlo Salvarani [Italie] ; Stefania Croci [Italie]Cytokine Profiling in Aqueous Humor Samples From Patients With Non-Infectious Uveitis Associated With Systemic Inflammatory Diseases
000F64 (2019) Francesco Muratore [Italie] ; Carlo Salvarani [Italie]Aortic dilatation in a patient with Takayasu arteritis treated with tocilizumab.
001135 (2018) Michael Schirmer [Autriche] ; Francesco Muratore [Italie] ; Carlo Salvarani [Italie]Tocilizumab for the treatment of giant cell arteritis.
001B26 (2016) Carlo Salvarani [États-Unis] ; Nicol Pipitone ; Gene G. HunderManagement of primary and secondary central nervous system vasculitis.
001E64 (2015) Olga Addimanda [Italie] ; Nicol Pipitone [Italie] ; Giulia Pazzola [Italie] ; Carlo Salvarani [Italie]Tocilizumab for severe refractory neuro-Behçet: three cases IL-6 blockade in neuro-Behçet.
002654 (2013) Nicol Pipitone [Italie] ; Carlo SalvaraniUpdate on polymyalgia rheumatica.
003811 (2012) Carlo Salvarani [Italie] ; Luca Magnani [Italie] ; Mariagrazia Catanoso [Italie] ; Nicolo Pipitone [Italie] ; Annibale Versari [Italie] ; Lucia Dardani [Italie] ; Lia Pulsatelli [Italie] ; Riccardo Meliconi [Italie] ; Luigi Boiardi [Italie]Tocilizumab: a novel therapy for patients with large-vessel vasculitis
000079 (2020) Caterina Vacchi [Italie] ; Marco Sebastiani [Italie] ; Giulia Cassone [Italie] ; Stefania Cerri [Italie] ; Giovanni Della Casa [Italie] ; Carlo Salvarani [Italie] ; Andreina Manfredi [Italie]Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review
000164 (2020) Giulia Cassone ; Andreina Manfredi ; Fabiola Atzeni ; Vincenzo Venerito ; Caterina Vacchi ; Valentina Picerno ; Federica Furini ; Gian Luca Erre ; Paola Tomietto ; Anna Laura Fedele [Italie] ; Giovanni Della Casa [Italie] ; Valeria Nucera ; Chiara Giannitti [Italie] ; Carlo Salvarani ; Marco SebastianiSafety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study
000233 (2020) Giulia Cassone [Italie] ; Marco Sebastiani [Italie] ; Caterina Vacchi [Italie] ; Stefania Cerri [Italie] ; Carlo Salvarani [Italie] ; Andreina Manfredi [Italie]Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming?
000613 (2020) Bernhard Hellmich [Allemagne] ; Ana Agueda [Portugal] ; Sara Monti [Italie] ; Frank Buttgereit [Allemagne] ; Hubert De Boysson [France] ; Elisabeth Brouwer [Pays-Bas] ; Rebecca Cassie [Royaume-Uni] ; Maria C. Cid [Espagne] ; Bhaskar Dasgupta [Royaume-Uni] ; Christian Dejaco [Autriche] ; Gulen Hatemi [Turquie] ; Nicole Hollinger [Allemagne] ; Alfred Mahr [France] ; Susan P. Mollan [Royaume-Uni] ; Chetan Mukhtyar [Royaume-Uni] ; Cristina Ponte [Portugal] ; Carlo Salvarani [Italie] ; Rajappa Sivakumar [Inde] ; Xinping Tian [République populaire de Chine] ; Gunnar Tomasson [Islande] ; Carl Turesson [Suède] ; Wolfgang Schmidt [Allemagne] ; Peter M. Villiger [Suisse] ; Richard Watts [Royaume-Uni] ; Chris Young [Royaume-Uni] ; Raashid Ahmed Luqmani [Royaume-Uni]2018 Update of the EULAR recommendations for the management of large vessel vasculitis.
000702 (2019) Andreina Manfredi [Italie] ; Giulia Cassone [Italie] ; Federica Furini [Italie] ; Elisa Gremese [Italie] ; Vincenzo Venerito [Italie] ; Fabiola Atzeni [Italie] ; Eugenio Arrigoni [Italie] ; Giovanni Della Casa [Italie] ; Stefania Cerri [Italie] ; Marcello Govoni [Italie] ; Luca Petricca [Italie] ; Florenzo Iannone [Italie] ; Carlo Salvarani [Italie] ; Marco Sebastiani [Italie]Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study.
000813 (2019) Sara Monti [Italie] ; Ana F. Águeda [Portugal] ; Raashid Ahmed Luqmani [Royaume-Uni] ; Frank Buttgereit [Allemagne] ; Maria Cid [Espagne] ; Christian Dejaco [Italie, Autriche] ; Alfred Mahr [France] ; Cristina Ponte [Portugal] ; Carlo Salvarani [Italie] ; Wolfgang Schmidt [Allemagne] ; Bernhard Hellmich [Allemagne]Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis
000A88 (2019) Carlo Salvarani [Italie] ; Gulen Hatemi [Turquie]Management of large-vessel vasculitis.
000A92 (2019) Ana F. Águeda [Portugal] ; Sara Monti [Italie] ; Raashid Ahmed Luqmani [Royaume-Uni] ; Frank Buttgereit [Allemagne] ; Maria Cid [Espagne] ; Bhaskar Dasgupta [Royaume-Uni] ; Christian Dejaco [Italie, Autriche] ; Alfred Mahr [France] ; Cristina Ponte [Portugal] ; Carlo Salvarani [Italie] ; Wolfgang Schmidt [Allemagne] ; Bernhard Hellmich [Allemagne]Management of Takayasu arteritis: a systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis
000C57 (2019) John H. Stone ; Katie Tuckwell ; Sophie Dimonaco ; Micki Klearman ; Martin Aringer ; Daniel Blockmans ; Elisabeth Brouwer ; Maria C. Cid ; Bhaskar Dasgupta ; Juergen Rech ; Carlo Salvarani ; Hendrik Schulze-Koops ; Georg Schett ; Robert Spiera ; Sebastian H. Unizony ; Neil CollinsonGlucocorticoid Dosages and Acute‐Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab
000D58 (2019) Jurgen Sota [Italie] ; Antonella Insalaco [Italie] ; Rolando Cimaz [Italie] ; Maria Alessio [Italie] ; Marco Cattalini [Italie] ; Romina Gallizzi [Italie] ; Maria Cristina Maggio [Italie] ; Giuseppe Lopalco [Italie] ; Francesco La Torre [Italie] ; Claudia Fabiani [Italie] ; Manuela Pardeo [Italie] ; Alma Nunzia Olivieri [Italie] ; Paolo Sfriso [Italie] ; Carlo Salvarani [Italie] ; Carla Gaggiano [Italie] ; Salvatore Grosso [Italie] ; Claudia Bracaglia [Italie] ; Fabrizio De Benedetti [Italie] ; Donato Rigante [Italie] ; Luca Cantarini [Italie]Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis
000F76 (2019) Jurgen Sota [Italie] ; Donato Rigante [Italie] ; Piero Ruscitti [Italie] ; Antonella Insalaco [Italie] ; Paolo Sfriso [Italie] ; Salvatore De Vita [Italie] ; Rolando Cimaz [Italie] ; Giuseppe Lopalco [Italie] ; Giacomo Emmi [Italie] ; Francesco La Torre [Italie] ; Claudia Fabiani [Italie] ; Alma Nunzia Olivieri [Italie] ; Marco Cattalini [Italie] ; Daniele Cammelli [Italie] ; Romina Gallizzi [Italie] ; Maria Alessio [Italie] ; Raffaele Manna [Italie] ; Ombretta Viapiana [Italie] ; Micol Frassi [Italie] ; Manuela Pardeo [Italie] ; Armin Maier [Italie] ; Carlo Salvarani [Italie] ; Rosaria Talarico [Italie] ; Marta Mosca [Italie] ; Serena Colafrancesco [Italie] ; Roberta Priori [Italie] ; Maria Cristina Maggio [Italie] ; Carla Gaggiano [Italie] ; Salvatore Grosso [Italie] ; Fabrizio De Benedetti [Italie] ; Antonio Vitale [Italie] ; Roberto Giacomelli [Italie] ; Luca Cantarini [Italie]Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease
001388 (2018) Arsene Mekinian [France] ; Mathieu Resche-Rigon [France] ; Cloé Comarmond [France] ; Alessandra Soriano ; Joel Constans [France] ; Laurent Alric [France] ; Patrick Jego [France] ; Florian Busato [France] ; Matthieu Cabon [France] ; Robin Dhote [France] ; Lazaro Estibaliz [France] ; Isabelle Koné-Paut [France] ; Cédric Landron [France] ; Christian Lavigne [France] ; Bertrand Lioger [France] ; Martin Michaud [France] ; Marc Ruivard [France] ; Karim Sacre [France] ; Jacques Eric Gottenberg [France] ; Francis Gaches [France] ; Tiphaine Goulenok [France] ; Carlo Salvarani ; Patrice Cacoub [France] ; Olivier Fain [France] ; David Saadoun [France]Efficacy of tocilizumab in Takayasu arteritis: Multicenter retrospective study of 46 patients.
001574 (2017) John H. Stone ; Katie Tuckwell ; Sophie Dimonaco ; Micki Klearman ; Martin Aringer ; Daniel Blockmans ; Elisabeth Brouwer ; Maria C. Cid ; Bhaskar Dasgupta ; Juergen Rech ; Carlo Salvarani ; Georg Schett ; Hendrik Schulze-Koops ; Robert Spiera ; Sebastian H. Unizony ; Neil CollinsonTrial of Tocilizumab in Giant-Cell Arteritis.
001735 (2017) Katie Tuckwell [Royaume-Uni] ; Neil Collinson [Royaume-Uni] ; Sophie Dimonaco [Royaume-Uni] ; Micki Klearman [États-Unis] ; Daniel Blockmans [Belgique] ; Elisabeth Brouwer [Pays-Bas] ; Maria C. Cid [Espagne] ; Bhaskar Dasgupta [Royaume-Uni] ; Juergen Rech [Allemagne] ; Carlo Salvarani [Italie] ; Sebastian H. Unizony [États-Unis] ; John H. Stone [États-Unis]Newly diagnosed vs. relapsing giant cell arteritis: Baseline data from the GiACTA trial.
001C88 (2016) Antonio Vitale [Italie] ; Antonella Insalaco [Italie] ; Paolo Sfriso [Italie] ; Giuseppe Lopalco [Italie] ; Giacomo Emmi [Italie] ; Marco Cattalini [Italie] ; Raffaele Manna [Italie] ; Rolando Cimaz [Italie] ; Roberta Priori [Italie] ; Rosaria Talarico [Italie] ; Stefano Gentileschi [Italie] ; Ginevra De Marchi [Italie] ; Micol Frassi [Italie] ; Romina Gallizzi [Italie] ; Alessandra Soriano [Italie] ; Maria Alessio [Italie] ; Daniele Cammelli [Italie] ; Maria C. Maggio [Italie] ; Renzo Marcolongo [Italie] ; Francesco La Torre [Italie] ; Claudia Fabiani [Italie] ; Serena Colafrancesco [Italie] ; Francesca Ricci [Italie] ; Paola Galozzi [Italie] ; Ombretta Viapiana [Italie] ; Elena Verrecchia [Italie] ; Manuela Pardeo [Italie] ; Lucia Cerrito [Italie] ; Elena Cavallaro [Italie] ; Alma N. Olivieri [Italie] ; Giuseppe Paolazzi [Italie] ; Gianfranco Vitiello [Italie] ; Armin Maier [Italie] ; Elena Silvestri [Italie] ; Chiara Stagnaro [Italie] ; Guido Valesini [Italie] ; Marta Mosca [Italie] ; Salvatore De Vita [Italie] ; Angela Tincani [Italie] ; Giovanni Lapadula [Italie] ; Bruno Frediani [Italie] ; Fabrizio De Benedetti [Italie] ; Florenzo Iannone [Italie] ; Leonardo Punzi [Italie] ; Carlo Salvarani [Italie] ; Mauro Galeazzi [Italie] ; Donato Rigante [Italie] ; Luca Cantarini [Italie]A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study
004417 (????) Olga Addimanda [Italie] ; Niccol Possemato ; Pierluigi Macchioni ; Carlo SalvaraniEfficacy and safety of tocilizumab in refractory rheumatoid arthritis: a real life cohort from a single centre.
004441 (????) Fabio Massimo Perrotta [Italie] ; Michelangelo Fici [Italie] ; Germano Guerra [Italie] ; Luca Brunese [Italie] ; Carlo Salvarani [Italie] ; Ennio Lubrano [Italie]Chronic periaortitis with retroperitoneal fibrosis successfully treated with first line tocilizumab monotherapy: a case report.

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021